Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2
US7468266B2 · kind B2 · utility
1Cited by
13References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 30, 2002 |
| Grant date | Dec 23, 2008 |
| Priority date | — |
| Expiry date | May 12, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/20
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human lipoprotein-associated phospholipase A2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.